News

Peloton’s (NASDAQ:PTON) Q4 Sales Beat Estimates, Stock Jumps 12.5%

Exercise equipment company Peloton (NASDAQ:PTON) announced better-than-expected revenue in Q4 CY2024, but sales fell by 9.4% year on year to $673.9 million. On the other hand, next quarter’s revenue guidance of $615 million was less impressive, coming in 6% below analysts’ estimates. Its GAAP loss of $0.24 per share was 25.9% below analysts’ consensus estimates.

Tapestry (NYSE:TPR) Posts Better-Than-Expected Sales In Q4, Stock Jumps 14.6%

Luxury fashion conglomerate Tapestry (NYSE:TPR) announced better-than-expected revenue in Q4 CY2024, with sales up 5.3% year on year to $2.20 billion. The company’s full-year revenue guidance of $6.85 billion at the midpoint came in 1.4% above analysts’ estimates. Its GAAP profit of $1.38 per share was 12.7% below analysts’ consensus estimates.

Omnicell (NASDAQ:OMCL) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $0.60 per share was 2.8% above analysts’ consensus estimates.